Adrian Gottschalk - Aug 17, 2023 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief Executive Officer, Director
Signature
/s /Allan Reine, M.D., Attorney-in-Fact for Adrian Gottschalk
Stock symbol
FHTX
Transactions as of
Aug 17, 2023
Transactions value $
$0
Form type
4
Date filed
8/18/2023, 04:03 PM
Previous filing
May 31, 2023
Next filing
Jan 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FHTX Common Stock Gift $0 -63K -100% $0.00* 0 Aug 17, 2023 Direct F1
transaction FHTX Common Stock Gift $0 +63K +14.04% $0.00 512K Aug 17, 2023 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 17, 2023, the Reporting Person transferred 63,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk Living Trust dated September 8, 2009. This was a bona fide gift with no payment in consideration.
F2 Consists of 300,000 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, of which the Reporting Person is the trustee and sole current beneficiary; 110,690 shares held by the Adrian H. Gottschalk 2021 Grantor Retained Annuity Trust dated November 29, 2021, of which the Reporting Person is the trustee and sole current beneficiary; and 101,014 shares held by the Adrian H. Gottschalk Living Trust dated September 8, 2009, of which the Reporting Person is the trustee